影响肝细胞癌患者肿瘤微血管侵犯的多因素分析*

doi:10.3969/j.issn.1672-5069.2024.01.024

摘要/Abstract

摘要： 目的探讨影响肝细胞癌(HCC)患者微血管侵犯(MVI)的危险因素。方法 2018年3月～2022年3月我院诊治的HCC患者206例,均接受MRI检查和肝段或肝叶切除术治疗,术后组织病理学检查诊断MVI。应用单因素和多因素Logistic回归分析影响HCC患者MVI形成的独立危险因素。结果在206例HCC患者中,组织病理学检查发现MVI 50例(24.3%);MVI组肿瘤直径≥5 cm和肿瘤细胞低分化分别为56.0%和58.0%,均显著高于非MVI组的32.7%和35.3%(P<0.05),而两组血清AFP水平400 ng/mL、Child-Pugh B级和肿瘤包膜是否完整占比无显著性差异(P>0.05);多因素非条件Logistic回归模型分析果显示,肿瘤≥5 cm和肿瘤细胞呈低分化为HCC患者并发MVI的独立危险因素(OR=1.166,OR=1.141,均P<0.05)。结论肿瘤直径大和细胞低分化为影响HCC患者并发MVI的独立危险因素,术前进行影像学检查了解肿瘤大小或可初步判断HCC患者是否存在MVI而进行必要的治疗准备可能有助于制定合理的手术方案。

关键词: 肝细胞癌, 磁共振成像, 肝叶切除术, 微血管侵犯, 多因素Logistic回归分析

Abstract: Objective The aim of this study was to investigate the risk factors for microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC). Methods 206 patients with HCC were encountered in our hospital between March 2018 and March 2022, and all underwent MRI and hepatectomy. The MVI was diagnosed by histopathology. The univariate and multivariate Logistic regression analysis were applied to predict the existence of MVI in patients with HCC. Results Out of the 206 patients with HCC, the MVI was found in 50 cases (24.3%); there were no significant differences as respect to serum AFP levels, Child-Pugh classes and the tumor envelope intact or not between patients with and without MVI(P>0.05), while the percentages of tumor diameter ≥5 cm and low tumor cell differentiation in patients with MVI were 56.0% and 58.0%, both much higher than 32.7% and 35.3% (P<0.05) in patients without MVI; the multivariate Logistic regression analysis showed that the tumor diameter ≥5 cm and low tumor cell differentiation were the independent risk factors for the existence of MVI in patients with HCC (OR=1.166, OR=1.141, bot P<0.05). Conclusion The large tumor and low differentiation of tumor cells are the independent risk factors of MVI happening in patients with HCC, and the preoperative imaging could help determine the size of tumors, and thus make the therapeutic strategy.

Key words: Hepatoma, Magnetic resonance imaging, Hepatectomy, Microvascular invasion, Multivariate Logistic regression analysis

许梁, 梁宏伟, 杜圣, 黄爱娜, 张涛. 影响肝细胞癌患者肿瘤微血管侵犯的多因素分析^*[J]. 实用肝脏病杂志, 2024, 27(1): 92-95.

Xu Liang, Liang Hongwei, Du Sheng, et al. Risk factors for microvascular invasion in patients with hepatocellular carcinoma[J]. Journal of Practical Hepatology, 2024, 27(1): 92-95.

参考文献

[1] Bray F,Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019, 16(10):589-604.
[3] 陈惠春, 涂海斌, 林健玲. 超声弹性成像联合血清学检查预测HCC MVI研究. 中华肝胆外科杂志, 2021, 27(10): 744-747.
[4] Lee S, Kim SH, Lee JE, et al. Preoperativegadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol,2017,67(3): 526-534.
[5] Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol, 2019, 70(6): 1133-1144.
[6] Ma X, Wei J, Gu D, et al. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol, 2019, 29(7): 3595-3605.
[7] Li M, Yin Z, Hu B, et al. MR elastography-based shear strain mapping for assessment of microvascular invasion in hepatocellular carcinoma. Eur Radiol, 2022, 32(7): 5024-5032.
[8] Wang WT, Yang L, Yang ZX, et al. Assessment of microvascular invasion of hepatocellularcarcinoma with diffusion kurtosis imaging. Radiology, 2018, 286(2): 571-580.
[9] Qi YP,Zhong JH, Liang ZY, et al. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion. Am J Surg, 2019, 217(4): 739-744.
[10] Chen J, Zhou J,Kuang S, et al. Liver imaging reporting and data system category 5 (LI-RADS LR-5): MRI predictors of microvascular invasion and recurrence after hepatectomy for hepatocellular carcinoma. AJR, 2019, 213(4): 821-830.
[11] Feng ST, Jia Y, Liao B, et al. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol, 2019 , 29(9): 4648-4659.
[12] 朱永健,冯冰,王炳智,等. 钆塞酸二钠增强磁共振成像联合磁共振扩散加权成像对肝细胞癌微血管侵犯和预后的预测价值. 中华肿瘤杂志, 2021, 43(3):312-317.
[13] 张坤,张天奇,谢双双,等. 基于钆塞酸二钠增强MRI的临床评分模型预测肝细胞癌微血管侵犯的多中心研究. 中华放射学杂志,2022,56(10):1115-1120.
[14] Ji GW, Zhu FP, Xu Q, et al.Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study radiology, 2020, 294(3): 191470.
[15] Wang XH, Long LH, Cui Y, et al. MRI-basedradiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma. Br J Cancer, 2020,122(7):978-985.
[16] 张煌斌, 鄢业鸿, 万昊, 等. 基于SII、AFP和肿瘤长径的HCC术前MVI的预测研究. 中华肝胆外科杂志, 2021, 27(10): 733-738.
[17] 赵晖, 陈骏, 严笑鹏,等. HCC患者MVI的组织学风险分级与预后的关系. 中华肝胆外科杂志, 2019, 25(6): 401-405.
[18] 刘红枝, 林海涛, 林昭旺, 等. 机器学习算法在HCCMVI术前预测中的应用价值. 中华消化外科杂志, 2020, 19(2): 156-165.
[19] Li Y, Xu X, Weng S, et al. CT image-based texture analysis to predict microvascular invasion in primary hepatocellular carcinoma. J Digit Imaging, 2020, 33(6): 1365-1375.
[20] Wang X, Wang W, Ma X, et al. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol, 2020, 30(10): 5337-5347.
[21] Zhang XP, Zhou TF, Wang ZH, et al. Association of preoperative hypercoagulability with poor prognosis in hepatocellular carcinoma patients with microvascular invasion after liver resection: a multicenter study. Ann Surg Oncol, 2019, 26(12): 4117-4125.
[22] Lian L, Bo L, Ming Z. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis. Acta Radiol, 2020,61(6): 723-731.
[23] Jiang H, Wei J, FuF,et al. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI. Liver Int, 2022, 42(5):1158-1172.
[24] Lee S, Kang TW, Song KD,et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg, 2021, 273(3):564-571.

影响肝细胞癌患者肿瘤微血管侵犯的多因素分析^*

Risk factors for microvascular invasion in patients with hepatocellular carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	倪裕丰, 倪国英, 杨志勇. 肝细胞癌组织BCLAF1和TCF3 RNA水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2024, 27(3): 418-421.
[2]	景红, 历媛, 孙小伶, 王丹. 肝脏占位病变患者增强MRI胆道系统图像质量最佳翻转角探讨^*[J]. 实用肝脏病杂志, 2024, 27(3): 426-429.
[3]	梅文娟, 李新, 张昊月. 超声造影时间-强度曲线相关参数鉴别诊断肝细胞癌与转移性肝癌价值研究^*[J]. 实用肝脏病杂志, 2024, 27(3): 430-433.
[4]	罗珂, 丁莉, 刘美. 肝细胞癌患者癌组织TTF-1、p53、p63表达变化及其对术后生存的影响^*[J]. 实用肝脏病杂志, 2024, 27(3): 434-437.
[5]	闫振, 赵博文, 林国英, 殷和良. 影像学三维可视化技术指导肝切除术治疗肝细胞癌患者临床疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(3): 438-441.
[6]	王倩文, 胡琳琳, 徐运军. 动态增强MRI联合血清SPINK1水平诊断原发性肝癌价值研究^*[J]. 实用肝脏病杂志, 2024, 27(3): 442-445.
[7]	高明慧, 柴梦音, 寇卜心, 豆双双, 刘晓霓. ASPP2重组腺病毒通过调控NF-κB信号通路抑制DEN诱导的小鼠肝细胞癌发生^*[J]. 实用肝脏病杂志, 2024, 27(2): 169-172, 173.
[8]	哈鹏, 苏晓晨, 付宾鹏. 三期增强CT扫描联合血清AFP和VEGF水平诊断肝细胞癌患者临床研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 251-254.
[9]	谢晶美, 刘浩, 李安, 李华, 陈苗苗, 郭宝琴, 石洋洋, 朱志敏, 郭晨光. 动态增强MRI定量参数术前评估原发性肝癌患者临床分期研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 255-258.
[10]	王莹莹, 周平, 程蕾. 右美托咪定复合七氟醚麻醉接受肝叶切除术治疗原发性肝癌患者麻醉效果分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 267-270.
[11]	张亚龙, 胡冬梅, 赵晟, 孟海生. 超声引导下射频消融治疗小原发性肝癌疗效及死亡危险因素分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 271-274.
[12]	崔甜甜, 张海波, 陈莉莉. 能谱CT增强扫描参数鉴别诊断肝血管瘤与肝细胞癌价值研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 275-278.
[13]	魏野, 汪施妤, 葛高华, 井桂银. CT增强扫描与磁共振检查诊断肝血管瘤和肝细胞癌价值分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 279-282.
[14]	章正威, 夏德鑫, 朱宝林, 章应峰, 王翔, 张彤. 早期原发性胆囊癌增强磁共振和CT扫描征象分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 311-313.
[15]	穆玉娟, 吴斐斐, 陈莹. 磁共振增强T1 mapping和IVIM-DWI技术评估乙型肝炎肝硬化患者肝脏储备功能价值研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 68-71.